About Gemelli Biotech
Gemelli Biotech is a private company based in Raleigh, North Carolina. It has reported $28,531,871 raised in three offerings on Form D since June 2019. Its chief executive is Matthew Mitcho.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 7, 2021 | Jun 8, 2022amended Dec 2, 2024 | $21,176,893of $23.9M target | 128 | $165K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Dec 23, 2019 | Mar 26, 2021amended Mar 29, 2021 | $5,500,000fully sold | 85 | $64,706 | DebtRule 506(b) | Form D/A ↗1 earlier filing |
| Jun 14, 2019 | Jun 28, 2019 | $1,854,978of $2.9M target | 13 | $142K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $28,531,871 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Gemelli Biotech's Form D filed Dec 2, 2024.
JN
John Neczesny
Director
MM
Matthew Mitcho
Chief Executive Officer and director
OL
Oded Levy
Director
RA
Ritish Agarwal
Director
JL
James Laur
Director
Earlier filings also listed Mark Pimentel (executive officer and director, last listed Mar 2021).